DNDi Template Development Collaboration and License Agreement Post author:GHIAA Admin Post published:April 14, 2023 Post category: Continue ReadingDNDi Template Development Collaboration and License Agreement
MPP – South African Medical Research Council, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement Post author:GHIAA Admin Post published:March 7, 2023 Post category: Continue ReadingMPP – South African Medical Research Council, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement
MPP – Afrigen Biologics, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement Post author:GHIAA Admin Post published:March 6, 2023 Post category: Continue ReadingMPP – Afrigen Biologics, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement
BIND Biosciences, Inc. – Yale University, Cancer Therapeutic, Exclusive License Agreement Post author:GHIAA Admin Post published:March 3, 2023 Post category: Continue ReadingBIND Biosciences, Inc. – Yale University, Cancer Therapeutic, Exclusive License Agreement
CEPI – VBI, COVID-19 Vaccine Development Funding Agreement Post author:GHIAA Admin Post published:December 12, 2022 Post category: Continue ReadingCEPI – VBI, COVID-19 Vaccine Development Funding Agreement
FIND Sample Funding Terms and Conditions Post author:GHIAA Admin Post published:December 7, 2022 Post category: Continue ReadingFIND Sample Funding Terms and Conditions
UnitaidExplore Sample Funding Terms and Conditions Post author:GHIAA Admin Post published:December 1, 2022 Post category: Continue ReadingUnitaidExplore Sample Funding Terms and Conditions
DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement Post author:GHIAA Admin Post published:October 26, 2022 Post category: Continue ReadingDNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
AXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement Post author:GHIAA Admin Post published:September 13, 2022 Post category: Continue ReadingAXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement